Arvind Sivasubramanian

Dr. Arvind Sivasubramanian


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
KAKhan Behlol Ayaz Ahmed
Khan Behlol Ayaz Ahmed
SSSwetha Subramanian
Swetha Subramanian
ASArvind Sivasubramanian
Arvind Sivasubramanian
GVGanapathy Veerappan
Ganapathy Veerappan
AVAnbazhagan Veerappan
Anbazhagan Veerappan

1 August 2016 in Journal of Molecular Liquids
Verified
Journal Article
Closed access
RSR. Sriranjani
R. Sriranjani
BSB. Srinithya
B. Srinithya
VVVadivel Vellingiri
Vadivel Vellingiri
PBPemaiah Brindha
Pemaiah Brindha
SASavarimuthu Philip Anthony
Savarimuthu Philip Anthony
MMMeenakshi Sundaram Muthuraman
Meenakshi Sundaram Muthuraman

1 January 2014 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
JSJanani Seralathan
Janani Seralathan
PSPriscilla Stevenson
Priscilla Stevenson
SSShankar Subramaniam
Shankar Subramaniam
RRRachana Raghavan
Rachana Raghavan
BPBrindha Pemaiah
Brindha Pemaiah
AVAnbazhagan Veerappan
Anbazhagan Veerappan

11 July 2013 in Pharmaceutical Biology
Verified
Journal Article
Closed access
SSShankar Subramaniam
Shankar Subramaniam
VRVenkatraman Ravi
Venkatraman Ravi
ASArvind Sivasubramanian
Arvind Sivasubramanian
Chromobacterium violaceum Bergonzini (Neisseriaceae), a Gram-negative bacterium, secretes a spectacular pigment called violacein. Violacein is a quorum-sensing metabolite and is also an active antimicrobial, anticancer agent. However, its efficiency as a potential drug, alone or in synergy with other active principles, has not being completely exploited. With the advent of different multi-drug resistant strains, it becomes essential to find a new natural product(s) that could be effectively used as a therapeutic agent. This work focused on the extraction of violacein from an isolated strain of C. violaceum and determined the combinatory effect of violacein with commercial antibiotics against various pathogens. Violacein production was optimized and was later extracted using ethanol and characterized by liquid chromatography-mass spectrometry and infrared spectroscopy. Then, individual minimum inhibitory concentration (MIC) values for each of the antibiotics were determined followed by violacein-commercial antibiotics (1:1) combinations, tested at different concentrations starting from 500 to 1 µg/ml against major pathogens. The individual MIC data for violacein was found to be 5.7 µg/ml (Staphylococcus aureus), 15.6 µg/ml (Klebsiella pneumoniae), 18.5 µg/ml (Pseudomonas aeruginosa), 20.0 µg/ml (Vibrio cholerae) and 5.7 µg/ml (Salmonella typhi). Violacein-gentamicin and violacein-cefadroxil combinations had MIC of 1.0 µg/ml against S. aureus. Most violacein-macrolide and violacein--aminoglycoside class combinations revealed fractional inhibitory concentration indices (FICI) of <0.5, thus exhibiting synergism. Furthermore, violacein-azithromycin and violacein-kanamycin combination, exhibited significant synergy (FICI-0.3) against S. typhi. Violacein works synergistically with most commercial antibiotics and could be used as drug in combination with other antimicrobial agents.

1 July 2019 in Microbial Pathogenesis
Verified
Journal Article
Closed access
RLRobert Lotha
Robert Lotha
BSBhanuvalli R. Shamprasad
Bhanuvalli R. Shamprasad
NSNiranjana Sri Sundaramoorthy
Niranjana Sri Sundaramoorthy
SNSaisubramanian Nagarajan
Saisubramanian Nagarajan
ASArvind Sivasubramanian
Arvind Sivasubramanian

1 November 2018 in Microbial Pathogenesis
Verified
Journal Article
Closed access
NSNiranjana Sri Sundaramoorthy
Niranjana Sri Sundaramoorthy
KMKartik Mitra
Kartik Mitra
JGJayasankari Senthil Ganesh
Jayasankari Senthil Ganesh
HMHima Makala
Hima Makala
RLRobert Lotha
Robert Lotha
SNSaisubramanian Nagarajan
Saisubramanian Nagarajan